- Home
- PRTA vs UHT Comparison
PRTA vs UHT Comparison
Compare PRTA & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTA | UHT |
|---|---|---|
| Founded | 2012 | 1986 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.1M | 561.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRTA | UHT |
|---|---|---|
| Price | $10.73 | $40.71 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $17.71 | N/A |
| AVG Volume (30 Days) | ★ 578.4K | 106.3K |
| Earning Date | 11-06-2025 | 10-27-2025 |
| Dividend Yield | N/A | ★ 7.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.30 |
| Revenue | $11,786,000.00 | ★ $100,898,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $672.02 | $0.81 |
| P/E Ratio | ★ N/A | $31.30 |
| Revenue Growth | N/A | ★ 1.00 |
| 52 Week Low | $4.32 | $34.56 |
| 52 Week High | $17.66 | $42.82 |
Technical Indicators
Market Signals| Indicator | PRTA | UHT |
|---|---|---|
| Relative Strength Index (RSI) | 57.52 | 60.89 |
| Support Level | $9.90 | $39.12 |
| Resistance Level | $10.91 | $41.68 |
| Average True Range (ATR) | 0.53 | 0.80 |
| MACD | 0.00 | 0.15 |
| Stochastic Oscillator | 72.39 | 65.58 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About UHT Universal Health Realty Income Trust
Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.